Claims for Patent: 6,881,407
✉ Email this page to a colleague
Summary for Patent: 6,881,407
Title: | Method for treating hepatitis |
Abstract: | Hepatitis can be treated by administering to a patient in need thereof an effective amount of a compound that neutralizes the effects of secreted TNFalpha. Two types of these compounds are extracellular ligand binding proteins of the human p75 TNF receptor, such as etanercept (Enbrel), and humanized monoclonal antibodies that neutralize the activity of TNFalpha, such as inflixamab (Remicade). |
Inventor(s): | Amin; Ashok (Union, NJ), Abramson; Steven (Rye, NY) |
Assignee: | |
Application Number: | 09/925,970 |
Patent Claims: | 1. A method for treating hepatitis C comprising administering to a patient in need thereof an effective amount of etanercept.
2. A method for treating hepatitis C comprising administering to a patient in need thereof an effective amount of infliximab. 3. A method for treating hepatitis C comprising administering to a patient in need thereof an effective amount of a compound that reduces viral levels in the patient wherein the compound that reduces viral levels is selected from the group consisting of infliximab and etanercept. 4. The method according to claim 3 wherein the compound is etanercept. 5. The method according to claim 3 wherein the compound is infliximab. |
Details for Patent 6,881,407
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2020-08-11 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2020-08-11 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2020-08-11 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2020-08-11 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.